Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
10.20
0.00 (0.00%)
At close: Aug 17, 2026
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $16.38 million as of August 18, 2026. Its market cap has decreased by -19.69% in one year.
Market Cap
16.38M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.20
ChartMarket Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 16.38M, a decrease of -98.37%. That is a compound annual growth rate of -53.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 16.38M | -24.37% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 32.91M |
| EOM Pharmaceuticals Holdings | 25.30M |
| Provectus Biopharmaceuticals | 23.05M |
| Oncotelic Therapeutics | 19.90M |
| ZIVO Bioscience | 17.81M |
| Synlogic | 14.27M |
| Inhibitor Therapeutics | 14.19M |
| Anebulo Pharmaceuticals | 13.05M |